Research Labs

The goal of the Strahle Lab is to understand germinal matrix hemorrhage-intraventricular hemorrhage (GMH-IVH)-induced brain injury and hydrocephalus in order to develop targeted therapeutics to prevent hydrocephalus, mitigate brain injury, and improve outcomes in infants with GMH-IVH.

The Ray Lab is interested in the development and validation of electrode/tissue interfaces for regenerative and rehabilitative applications.

The Stegh Lab aims to understand and therapeutically target the genetic program that underlies the pathogenesis of glioblastoma.

Developing high-throughput technologies to study cell-cell interactions. Decoding the metastatic tumor microenvironment. Identifying therapeutic targets in cancer-stroma interactions to fight metastatic cancer.

The Thompson Lab investigates the molecular mechanisms of and treatment for leptomeningeal dissemination of pediatric brain tumors, focusing on the Abelson family of nonreceptor tyrosine kinases (ABL1 and ABL 2).

Focusing on characterizing the function of brain circuits that control memory and arousal in normal and disease states.

Identify molecular mechanisms of neurodegeneration in Huntington’s disease.

The YE Li Lab investigates both the genetic and epigenetic contributions to human diseases, particularly in brain tumors and neuropsychiatric disorders.

The Zipfel Lab aims to understand the mechanisms driving acute and chronic cerebrovascular diseases, identify new molecular targets, and develop novel therapies that will improve the lives of our patients.